Literature DB >> 8641171

Regulation of the insulin-like growth factor system by acute acidosis.

A Bereket1, T A Wilson, A J Kolasa, J Fan, C H Lang.   

Abstract

Many catabolic conditions are characterized by disturbances in acid-base balance and concomitant alterations in the insulin-like growth factor (IGF) system. However, the influence of acidosis per se on the various components of the IGF system has not been extensively examined. The purpose of the present study was to determine the effect of acute metabolic acidosis on the plasma and tissue concentrations of IGF-I and the various IGF-binding proteins (IGFBPs). Conscious unrestrained fasted rats were infused iv with either 0.2 N HCl or an equal volume of saline for 4 h. The arterial blood pH decreased within 60 min after starting the HCl infusion and remained lower than time-matched control values for the entire experimental protocol. Although the plasma IGF-I concentration fell gradually and was reduced by 30%, compared to time-matched control values, GH levels were unaltered. The IGF-I content of tissues collected at the conclusion of the experiment was increased in liver (35%) and kidney (63%), and unchanged in skeletal muscle. However, whereas acidosis moderately increased IGF-I messenger RNA abundance in liver, no significant alteration in IGF-I expression was detected in kidney. Acidosis also increased the plasma levels of IGFBP-1 and -2 as well as the IGFBP-1 content of liver and kidney. In contrast, the concentration of intact IGFBP-3 was decreased in acid-infused rats, and this reduction was associated with an increased rate of IGFBP-3 protease activity. Acidotic rats demonstrated unremarkable changes in the plasma concentrations of glucose and insulin, but corticosterone levels were elevated throughout the experiment. The results of the present study demonstrate that in the absence of underlying pathology, acute metabolic acidosis decreases circulating levels of IGF-I, probably by increasing renal clearance of the peptide, not by decreasing hepatic IGF-I synthesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641171     DOI: 10.1210/endo.137.6.8641171

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

Review 1.  Cellular actions of insulin-like growth factor binding proteins.

Authors:  R J Ferry; L E Katz; A Grimberg; P Cohen; S A Weinzimer
Journal:  Horm Metab Res       Date:  1999 Feb-Mar       Impact factor: 2.936

Review 2.  Genetics, chemistry, and function of the IGF/IGFBP system.

Authors:  P F Collett-Solberg; P Cohen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.633

3.  Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence.

Authors:  S Röjdmark; K Brismar
Journal:  J Endocrinol Invest       Date:  2001 Jul-Aug       Impact factor: 4.256

Review 4.  Diabetes mellitus and electrolyte disorders.

Authors:  George Liamis; Evangelos Liberopoulos; Fotios Barkas; Moses Elisaf
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 5.  Calcium homeostasis in diabetes mellitus.

Authors:  Changhwan Ahn; Ji-Houn Kang; Eui-Bae Jeung
Journal:  J Vet Sci       Date:  2017-09-30       Impact factor: 1.672

6.  Severe hypercalcemia in diabetic ketoacidosis: a case report.

Authors:  Tafadzwa Makaya; Sumana Chatterjee; Paul Arundel; Cliff Bevan; Neil P Wright
Journal:  Diabetes Care       Date:  2013-04       Impact factor: 19.112

Review 7.  Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact.

Authors:  Vik R Rajan; William E Mitch
Journal:  Pediatr Nephrol       Date:  2007-11-07       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.